CoJourney
Latest round
- Series A
Last raised
- Jun 2023
Total raised
- $30M
Investors
- 6
About CoJourney
Based in Pennsylvania, US, and founded in 2021, CoJourney Inc. operates as a pharmaceutical company that is a manufacturer of cell and gene therapies through platform technologies such as plasmids, mRNA, etc. In July 2023, CoJourney Inc. CoJourney Inc. is a company that provides a CDMO (Contract Development and Manufacturing Organisation) platform for gene therapy that is designed for plasmids, viral vectors, and mRNA. The company's platform includes the creation, analysis, and testing of genetic materials. As a result, gene therapy developers are able to obtain access to personalized services such as process development, cGMP manufacturing, analytical method development, and product release testing.
Who invested in CoJourney
6 investors across 1 round
See all investors in CoJourney
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 26, 2023
Amount
$30M
Investors
Questions about CoJourney
Who invested in CoJourney?
CoJourney has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CoJourney raised?
CoJourney has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did CoJourney last raise money?
CoJourney's most recent round on record is a Series A, in Jun 2023.
What does CoJourney do?
Based in Pennsylvania, US, and founded in 2021, CoJourney Inc.
Where is CoJourney headquartered?
CoJourney is headquartered in Philadelphia, US.
Which VCs invest in companies like CoJourney?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at CoJourney's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like CoJourney? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.